Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma
Karina Biserova, Arvīds Jakovļevs, Romans Uljanovs, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 621-621
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis
Yang Jiang, Junshuang Zhao, Rongqing Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 88
Immunotherapy: a promising approach for glioma treatment
Feroza Yasinjan, Xing Yang, Huayue Geng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 80
Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy
Wenya He, Xiaozhe Li, Marco Morsch, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 6293-6308
Closed Access | Times Cited: 76
Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases
Qian Lu, Yanli Zhu, Chao Deng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 75
A developmental constraint model of cancer cell states and tumor heterogeneity
Ayushi Patel, Itai Yanai
Cell (2024) Vol. 187, Iss. 12, pp. 2907-2918
Closed Access | Times Cited: 26
Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma
Jun Yang, Yong Li, Shaoping Jiang, et al.
Exploration (2024)
Open Access | Times Cited: 20
The strategies to cure cancer patients by eradicating cancer stem-like cells
Yansui Mai, Jiyan Su, Chuan Yang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 38
Sonodynamic therapy and magnetic resonance-guided focused ultrasound: new therapeutic strategy in glioblastoma
Lapo Bonosi, Silvia Marino, Umberto Emanuele Benigno, et al.
Journal of Neuro-Oncology (2023) Vol. 163, Iss. 1, pp. 219-238
Open Access | Times Cited: 26
Cancer stem cells and their niche in cancer progression and therapy
Qiuping Liu, Zongliang Guo, Guoyin Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
The hidden architects of glioblastoma multiforme: Glioma stem cells
Om Saswat Sahoo, Rhiti Mitra, Naveen KH Nagaiah
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Antibiotics treatment promotes vasculogenesis in the brain of glioma-bearing mice
Maria Rosito, Javeria Maqbool, A. Reccagni, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 8
Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics
Gerhard Nahler
Pharmaceutical Medicine (2022) Vol. 36, Iss. 2, pp. 99-129
Open Access | Times Cited: 33
Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy
Andrew M. Hersh, Hallie Gaitsch, Safwan Alomari, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3743-3743
Open Access | Times Cited: 30
Signaling pathways governing glioma cancer stem cells behavior
Ava Nasrolahi, Shirin Azizidoost, Klaudia Radoszkiewicz, et al.
Cellular Signalling (2022) Vol. 101, pp. 110493-110493
Closed Access | Times Cited: 29
B7-H3 in Brain Malignancies: Immunology and Immunotherapy
Xiaopeng Guo, Mengqi Chang, Yu Wang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3762-3780
Open Access | Times Cited: 20
circCIMT Silencing Promotes Cadmium‐Induced Malignant Transformation of Lung Epithelial Cells Through the DNA Base Excision Repair Pathway
Meizhen Li, Wei Chen, Jinjin Cui, et al.
Advanced Science (2023) Vol. 10, Iss. 14
Open Access | Times Cited: 18
Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers
Lloyd A. Greene, Qing Zhou, Markus D. Siegelin, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 581-581
Open Access | Times Cited: 17
CD133 significance in glioblastoma development: in silico and in vitro study
Mahdi Abdoli Shadbad, Fatemeh Nejadi Orang, Behzad Baradaran
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 6
FOSL1’s Oncogene Roles in Glioma/Glioma Stem Cells and Tumorigenesis: A Comprehensive Review
Azam Khedri, Shanchun Guo, Ramar Vanajothi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5362-5362
Open Access | Times Cited: 6
Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets
Ashley Irin Cortes Ballen, Maryam Amosu, Surya Ravinder, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1574-1574
Open Access | Times Cited: 6
Nanomedicines Targeting Glioma Stem Cells
Arjun Sabu, Te‐I Liu, Siew Suan Ng, et al.
ACS Applied Materials & Interfaces (2022) Vol. 15, Iss. 1, pp. 158-181
Closed Access | Times Cited: 26
Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory Activities
Hadar Peeri, Hinanit Koltai
Biomolecules (2022) Vol. 12, Iss. 4, pp. 491-491
Open Access | Times Cited: 23
Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma
Roman Bubin, Romans Uljanovs, Ilze Štrumfa
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7030-7030
Open Access | Times Cited: 15
Biomarkers and targeted therapy for cancer stem cells
Yusheng Liu, Hua Wang
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 56-66
Closed Access | Times Cited: 14
Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo–Chemo-Immunotherapy
Ruotian Zhang, Yicheng Ye, Jianing Wu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 14, pp. 17627-17640
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top